Article
Influence of Genetic Polymorphisms and Concomitant Anxiolytic Doses on Antidepressant Maintenance Doses in Japanese Patients with Depression.
Biological & pharmaceutical bulletin - 1 Sept 2016
Inoue Kazuyuki, Murofushi Takuma, Nagaoka Kakeru, Ando Natsuko, Hakamata Yasuhiro, Suzuki Akiko, Umemura Akiko, Yoshida Yuko, Hirai Keita, Tsuji Daiki, Itoh Kunihiko
Abstract excerpt
To prevent recurrent depression, patients should ideally continue treatment for >6 months with the antidepressant dose that effectively suppressed acute depressive symptoms. However, there are inter-individual differences in the antidepressant doses required to achieve response and maintenance. Therefore, this study was conducted to examine the role of clinical features, including genetic polymorphisms, on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.